michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks for the question, Nigel. Yes. So it is a factor. So we did do the testing on the LRT, and we had good news, I would say, as expected.
And when you have a positive margin, that means no charge to the P&L. Yes, and the margin was 11% positive, which is significantly higher than what we have seen. It was mainly driven by the discount rate increase. It increased from 5.7% to 6.15%.
And I would say that increase was really driven by asset allocation and really, our plan to increase the amount allocated to growth assets, where we're going from [ nine to 15 ]. The other variables had -- like morbidity and mortality, inflation in premium, they were a small impact. So we're really happy with that. And your question then on top of that, sort of for CFT, so CFT or the cash flow testing, that is what decides, yes, if there's a need to add cash to the insurance.
I would say like this, it's not one to one. Yes, the variables are similar to LRT, but they are used under moderately adverse conditions. I would say the modeling will happen beginning of next year, as usual. We will look at our investment portfolio realignment and the changes factored into that model.
Also look at the future cash flow. But it could have some adverse effect because we're using more granular assumptions. But I would say, overall, the good news from the LRT bodes very well for the CFT, but it's not one to one.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's a good question. Our Care Guides solution typically can be launched more quickly than the full digital platform for a customer that's already live. And so the kind of time needed is six to eight weeks. But in terms of client strategy, they're typically, at this point of the year, going to be looking at 1/1.
And so you're correct that in those conversations, we're most likely talking about '22 revenue contribution.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks. Good morning. Sorry to hound on the gross margin again but I just want to make sure I understand. The going from the negative 4% gross margin last quarter to 12%, so quite a significant recovery.
So was that more due to changes in your product mix? Or was that largely because you're producing more and so you have those economies of scale? I guess, was it more due to the latter?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I'll remind you, the gas in New Zealand is very wet gas. So there are lots of barrels of liquids and oil prices have any [Phonetic] that really helps the economics and they're really going after the liquids. So a higher energy complex in general is positive for our business and that's one of the reasons it incentivizes more exploration and development. Yeah, situation in New Zealand really was the [Indecipherable] field failed and that lost 30% of its production late last year and nobody was expecting that and that's caused the gas market to tighten up quite substantially. The current situation in their winter as well.
They had a lack of rainfall, which is leading to lower than expected hydro power, it's rained again in New Zealand. So that situation is behind us now and there is drilling going on. I think that's the positive thing for us is that the upstream owners of the field, Maui and Pohokura are drilling and planning to drill more, so we'll know a little bit more in the next 12 months. The results of those drilling and like I said, we're certainly contracted for two plants for the, to the end of the decade and we're optimistic the drilling will be successful and we'll see a third might have a reasonable opportunity to start-up as well.
This is not new in New Zealand, we've seen this before, and they pretty well develop the reserves and the country needs them. So yeah, we're optimistic, but really I think we'd be modeling a two-plant operation at this point until we see the results of what's happening in the upstream.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
You bet, Neal.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. No, we're still -- our focus is really on the refinery, petrochemical side, the LNG side, both in terms of liquefaction and the receiving terminals. The only real upstream part that we have, and it's been a steady performer for our business for a long time, not a big growth area, but we have a very high market share. And these are these so-called pipe-in-pipe subsea programs that we have.
We typically say that's, in any given year, it's about a $10 million business, plus or minus $5 million. It's been kind of in that range for a long time. It's solid business for us. We're very good at it, and we like that business.
But most of our work comes in the refiners, with the refiners, with the petrochemical guys, and of course, with the LNG side of it.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Absolutely.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. I just had a follow-up on the response to one of your earlier questions. You mentioned the possibility of repurposing a pipe this year to service, but I was under the impression that this is pretty difficult to do with the liquids pipeline and may be possible with a gas pipeline since the CO2 pipelines require, you know, separate pipelines and a lot more compression. So, curious as to your thoughts here on how capital-intensive that you can -- version could be.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks Tim.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. We've got little bit over 100 basis points improvement for the full year for North America. Some of the improvement as you point out, it came in the first quarter, we had a really good first quarter and the higher production levels and pricing that we expect to get we think can support that margin improvement. The one negative area I'd point out is we do get a little bit of a hit on foreign exchange impacts. We import product from Europe into North America. And so that with the stronger euro is giving us a little bit of a tighter margin on our North America results. But obviously overall with our strong European profits, those are offset by translation benefit. So to the company's bottom line, it's not a big impact, but it does show up in the margins for North America. But overall margin improvement is expected in North America, expect to get to double-digit margins this year.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
OK. So let's start with the easy one. The 15 million, that's exactly how you described it, that's basically costs that we didn't have last year because of some of the benefits that were how they might get the government and some of the other onetime benefits to manage through COVID. So those are sort of back to normal levels.
In terms of the $30 million, I would say the difference here is we did OK in the second quarter, much better than we expected. We thought we'd see a bit of that impact in the second quarter. We did have some impact but it's really moved at all to the second half. So the last time we talked about that, I really thought the $30 million will hit over the second, third, and fourth quarter of today.
I would is more heavily weighted to the third and fourth quarter. And then in terms of some additional costs, we have baked in some additional costs in SG&A for our new product development initiatives. And they really don't start to kick in until the second half.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
All right. We'll have our last question, please.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So let me make a comment and then see if Eric wants to add anything. So we do expect that the EFS analysis will be completed around the same time. The EFS analysis on the so-called Phase 2 portion of that study would be completed around the same time as we get our data from our company-sponsored Phase 3 trial. And if that data is sufficiently positive, that could -- we could potentially file on that data. So there are several possible outcomes at that point. One is that we could file on that data. Another is that it's positive, but the study would also continue toward its Phase 3 survival endpoint or, of course, could be negative, we're obviously hoping that's not the outcome. But there are a number of possible outcomes at that point. We do anticipate, though, that the event-free survival analysis on that first group of patients would be performed at around the same time as the survival analysis on our -- as overall survival analysis in our study.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We have seen pretty, let's say, several cases canceled by the shipping line companies, but we always can find some solutions because we have these multiyear shipping line contracts with all the major shipping lines. So even if they cancel the shipments or the shipping lines this week or next week, we can always try to find out a solution to squeeze them in for the next one in the, I don't know, next months or the months after, right?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, Mark, I got to tell you, I mean, the exciting part is it's so broad-based, and it's across the board -- across all of our business units. I think that's what's contributing in many respects to why our business is -- all of our businesses are growing double digits. Now when you think of DTC, it really gives us the opportunity to bring new products to light faster. So where we have exciting new products and we need to get them to market fast, it really enables us to overnight launch this to the consumer.
Now we're excited to tie ammunition to Hunt, Shoot Accessories to even brands like QuietKat or to Camp Chef is really behind the scenes, right? We're running on a singular platform that allows us to leverage technology where we can cross promote. So things like loyalty programs or things like subscription really help not just our ammunition business, but you'll see us roll it across all of our Outdoor Products businesses and where we have light consumers, and we have lots of light consumers across our brands, that's where we can really tie it together.
And that's why we really reinforced the fact that, hey, we're in the early innings. I mean, we said before, we said at our Investor Day that listen, best-in-class today is kind of 30% to 35% overall online business and a large part of the great companies are moving toward DTC. We're a fraction of that. And despite being hundreds of millions of dollars in our e-comm online business, there's a lot more to come.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, it's a terrific question, Ketan. I think we -- we will -- already have expanded over last year where the wood, plastic composite lines that we think were in good shape there. Our mineral composite line is growing very rapidly. And we do have a longer lead time there. So, look,[Phonetic] we are being a little more selective in the customers and the products that we're moving. So I would say, if the demand continues as strong as it is, we might be a little bit short on the ability to take on a lot more customers on the mineral composite line this year until Q4.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Look, I don't think we're capacity-constrained. Within the windows that we talk about, just in general, that we think that we -- there is no upper limit, right? We'll continue to work it, we continue to invest. Certainly, there's some time to some of the lead time on our parts, but whether it's facilities, we like to think about people, parts, and space at KLA.
Typically, our long goal is around parts around some of the components we talked about. So we're going to continue to add capacity and send strong signals into supply chain to drive the investments that are required. And we'll -- based on customer readiness and customer expectations, we'll do what we need to, to continue to support those activities as we go forward even beyond 2021. So I'm not worried about our ability.
I'm worried that we're challenged and it's not easy and there's a lot of work going on here. But at the same time, we know how to do this, and we'll continue to make the investments that are required to get the capacity to support the environment we're in.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you. Good morning. I want to ask about Nets. Now that you've had it for a couple of months, it was, I guess, a little different than what you originally agreed to buy.
So given that, what are the priorities here, Michael, both short term and long term? It sounds like Europe is clearly part of it. But can you just catch us up on your to-do items right now?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Jay.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So look, with the price and productivity, we offset inflation. That's usually the way we go at it. And that's the way we're thinking about this one. Obviously, on the inflation side though, because it's commodities and we have locks in place as you guys know, and those take us through the end of June, depending on how commodities progress through the rest of the year, we might be looking at price again. But for now, it's that 3% to 5% that Bob mentioned, with a 1% to 2% realization rate.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think that you're talking about the click and collect experience. Is that right?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Thanks, Peter. In the past, I've had the opportunity to bring drugs to market in multi-myeloma, specifically working on Kyprolis. And I think as we know, in many areas when you first launch in later stages of the disease and then work to move up, we need to continue to work with physicians to help them better understand the medicine, help them understand how to initiate and manage patients, and that's a process that takes time, but one which we're committed to moving forward.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's pretty much so. It's not 100% perfect, but it will get you within spitting distance of the number.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No, it absolutely is higher expectations for new sales that is raising. And really, if you look back to when we first introduced the 6% to 8% back in 2015 in connection with the IPO, a revenue growth bridge at that point would not have had an innovation line. You would have had a platform sales line, it would've had price with a loan growth, it would've had an attrition assumption. But what's incremental today is, it's really the innovation bar or step in that guidance. And so, that's really where that change comes in, but it's new sales.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you once again for joining us today. If you have any other questions, please feel free to contact us through the contact information on our website or The Piacente Group, our investor relations consultant. Thank you all. Have a good night.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey. Good afternoon, guys.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Thanks Emily. Good to hear from you. First of all, as far as COVID, obviously I don't know the answer to what's going to happen in the future. As we, as I stated earlier, we should have everything remediated by the end of the year, which would mean a early first quarter we could resubmit. The FDA did say they want to do an onsite inspection. What I can tell you, though, is today, as an example, you can travel to Korea. We have people going there actively, so I'm not sure what will happen with COVID in the future.
But certainly, certainly right now you can travel to Korea. So we're doing it as we speak. So that's the first part of the question. So we don't know exactly when now they would send the inspector. I can tell you that it would be a six months review, that doesn't mean it would take six months. So any time after we file, they could send an inspector back to do a reinspection. Now as far as the Cohort 4 question Francois why don't you take that?

    Prediction (one of UP, DOWN, SAME): SAME